Get started
Egyptian International Pharmaceutical Industries Co.Egyptian International Pharmaceutical Industries Co.Egyptian International Pharmaceutical Industries Co.

Egyptian International Pharmaceutical Industries Co.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

PHAR chart


Full chart

PHAR upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪10.46 B‬ EGP
Dividend yield (indicated)
4.84%
Price to earnings Ratio (TTM)
8.417
Basic EPS (TTM)
7.366 EGP
Net income (FY)
‪1.10 B‬ EGP
Revenue (FY)
‪7.59 B‬ EGP
Shares float
‪84.37 M‬
Beta (1Y)
0.56

About Egyptian International Pharmaceutical Industries Co.


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Ahmed Said Mohammed Kilany El-Bucheiry
Website
eipico.com.eg
Headquarters
Tenth of Ramadan City
Founded
1980
ISIN
EGS38081C013
FIGI
BBG000G1YHX8
Egyptian International Pharmaceutical Industries Co. engages in the manufacture and distribution of medicines and other medical products. Its products include anesthetics, analgesics, antibiotics, antacids, decongestants, diuretics, laxatives, blood substitutes, vitamins, and minerals. The company was founded on December 3, 1980, and is headquartered in Tenth of Ramadan City, Egypt.

Check out other big names from the same industry as PHAR.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PHAR news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PHAR is 61.450 EGP — it has decreased by −0.89% in the past 24 hours. Watch Egyptian International Pharmaceutical Industries Co. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange Egyptian International Pharmaceutical Industries Co. stocks are traded under the ticker PHAR.
PHAR stock has risen by 13.80% compared to the previous week, the month change is a 17.72% rise, over the last year Egyptian International Pharmaceutical Industries Co. has showed a 47.36% increase.
We've gathered analysts' opinions on Egyptian International Pharmaceutical Industries Co. future price: according to them, PHAR price has a max estimate of 90.00 EGP and a min estimate of 90.00 EGP. Watch PHAR chart and read a more detailed Egyptian International Pharmaceutical Industries Co. stock forecast: see what analysts think of Egyptian International Pharmaceutical Industries Co. and suggest that you do with its stocks.
PHAR reached its all-time high on Jan 2, 2018 with the price of 94.146 EGP, and its all-time low was 4.184 EGP and was reached on May 12, 2003. View more price dynamics on PHAR chart.
See other stocks reaching their highest and lowest prices.
PHAR stock is 3.95% volatile and has beta coefficient of 0.56. Track Egyptian International Pharmaceutical Industries Co. stock price on the chart and check out the list of the most volatile stocks — is Egyptian International Pharmaceutical Industries Co. there?
Today Egyptian International Pharmaceutical Industries Co. has the market capitalization of ‪10.37 B‬, it has increased by 2.26% over the last week.
Yes, you can track Egyptian International Pharmaceutical Industries Co. financials in yearly and quarterly reports right on TradingView.
Egyptian International Pharmaceutical Industries Co. is going to release the next earnings report on Oct 20, 2025. Keep track of upcoming events with our Earnings Calendar.
PHAR net income for the last quarter is ‪111.94 M‬ EGP, while the quarter before that showed ‪204.87 M‬ EGP of net income which accounts for −45.36% change. Track more Egyptian International Pharmaceutical Industries Co. financial stats to get the full picture.
Egyptian International Pharmaceutical Industries Co. dividend yield was 6.53% in 2024, and payout ratio reached 40.73%. The year before the numbers were 5.38% and 36.18% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Egyptian International Pharmaceutical Industries Co. EBITDA is ‪1.61 B‬ EGP, and current EBITDA margin is 21.20%. See more stats in Egyptian International Pharmaceutical Industries Co. financial statements.
Like other stocks, PHAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Egyptian International Pharmaceutical Industries Co. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Egyptian International Pharmaceutical Industries Co. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Egyptian International Pharmaceutical Industries Co. stock shows the strong buy signal. See more of Egyptian International Pharmaceutical Industries Co. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.